Dr. Agarwal's Health Care Limited announced that the National Company Law Tribunal (NCLT), Chennai Bench, has sanctioned the scheme of amalgamation involving Dr. Agarwal's Eye Hospital Limited.

The order was pronounced during a hearing held on September 30, 2026, and uploaded to the NCLT website on October 5, 2026. The certified copy of the order is awaited and will be made available on the company website upon receipt.

Scheme timeline and effectiveness

The amalgamation provides for Dr. Agarwal's Eye Hospital Limited to merge with and into Dr. Agarwal's Health Care Limited. The scheme is governed by Sections 230 to 232 of the Companies Act, 2013.

According to the filing, the scheme shall be effective from the Appointed Date, which is the opening of business on April 1, 2026. The operative date will be the first day of the calendar month immediately following the completion of all conditionalities mentioned in Clause 24 of the scheme.

Key dates and procedural status

The company stated it will keep stock exchanges informed regarding the effectiveness of the scheme, fixation of the record date, allotment of shares as per the share exchange ratio, and other subsequent developments.

What the numbers show

The gap between the appointed date (April 1, 2026) and the sanction date (September 30, 2026) indicates a retroactive accounting effect for over five months. This means financial statements for the period between April and September 2026 will likely require restatement or consolidation adjustments to reflect the combined entity's performance from the start of the fiscal year.

Dr. Agarwal's Health Care Limited confirmed on September 29, 2026, that Orbit Healthcare Services Nigeria Ltd has become a step-down wholly owned subsidiary through Orbit Healthcare Services (Mauritius) Limited.

The development follows an intimation received from Orbit Mauritius, which is a direct wholly owned subsidiary of the company. Consequently, the Nigerian entity is now both a wholly owned subsidiary of Orbit Mauritius and an indirect step-down wholly owned subsidiary of Dr. Agarwal's Health Care Limited.

Regulatory Disclosure

The company filed this update with BSE and NSE under Regulation 30(7) read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure serves as a continuation of an earlier letter dated August 4, 2026, regarding the proposed establishment of the step-down subsidiary in Nigeria.

Corporate Structure Update

The confirmation solidifies the corporate structure involving the company's international operations. The key entities involved in this structure are outlined below:

The company stated that it has received formal confirmation regarding the completion of this corporate action. The filing was signed by Thanikainathan Arumugam, Company Secretary and Compliance Officer, on September 29, 2026.